Paloxiron 0.25 mg/5 ml (IV Injection)
5 ml ampoule: ৳ 100.00 (1 x 5: ৳ 500.00)
Medicine Details
Category | Details |
---|---|
Generic | Palonosetron |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV)
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV)
Pharmacology
- 5-HT3 receptor antagonist
- Binding affinity for serotonin receptor
- Pharmacokinetics
- Metabolism
- Plasma protein binding
- Drug clearance
- Half-life
- Receptor binding affinity
Dosage & Administration
- Usual Adult dosage
- Chemotherapy-induced nausea and vomiting dosage
- Radiotherapy-induced nausea and vomiting dosage
- Post-operative nausea and vomiting dosage
- Children dosage
Interaction
- Safe administration with corticosteroids, analgesics, antiemetics/antinauseants, antispasmodics, anticholinergic agents
- No inhibition of antitumor activity
- No significant pharmacokinetic interactions
- Not inhibitor of CYP enzymes
- Low potential for drug interactions
Contraindications
- Hypersensitivity to the drug or its components
Side Effects
- Headaches
- Constipation
Pregnancy & Lactation
- Pregnancy category 'B'
- Excretion in breast milk unknown
Use in Special Populations
- Elderly patients dosage
- Children dosage
- Use in patients with impaired renal and hepatic function
Overdose Effects
- No known antidote
- Manage with supportive care
Therapeutic Class
- Anti-emetic drugs
Storage Conditions
- Store in a cool & dry place
- Protected from light
Related Brands
- Paloron 0.075 mg/1.5 ml (IV Injection) - ziska-pharmaceuticals-ltd
- Paloron 0.25 mg/5 ml (IV Injection) - ziska-pharmaceuticals-ltd
- Paloron 0.5 mg (Tablet) - ziska-pharmaceuticals-ltd
- Paloxi 0.5 mg (Capsule) - beacon-pharmaceuticals-plc
- Paloxi 0.075 mg/1.5 ml (IV Injection) - beacon-pharmaceuticals-plc